Journal of Proteome Research · 2006 · 56 citations · 22 references
Life SciencesBiochemistryMolecular BiologyMolecular OncologyPost-translational ModificationProteomicsCancer BiomarkersCancer ProteomicsOvarian CancerPlasma ProteinsPost-translational RegulationProtein PhosphorylationGel ElectrophoresisIsoform Differential ExpressionOvarian Cancer BiomarkersOvarian Tumor BiomarkersPlasma Protein BiomarkersPolyacrylamide Gel ElectrophoresisSerum Protein BiomarkersWestern Blot Analysis
We evaluated the differentially expressed proteins in the plasma of ovarian cancer (OVC) patients using 2-D SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with post-translational modification (PTM) specific stains after the removal of six high-abundance proteins. The pooled plasma from patients with stage III or IV OVC was compared to a pooled postmenopausal age-matched control. Several proteins were identified as differentially expressed in the plasma of OVC patients. Among them, the phosphorylated fibrinogen-alpha-chain isoform (containing fibrinopeptide-A) was found to be up-regulated. Previously in our laboratory, phosphorylated fibrinopeptide-A was found to be up-regulated in the low molecular weight fraction of serum derived from OVC patients. We examined the levels of phosphorylated fibrinogen-alpha-chain in each patient that constituted the pooled plasma using Western blot, mass spectrometry (MS), and PTM specific stains. Phosphoprotein bands containing fibrinogen-alpha-chain fragments showed up-regulation in all OVC patients.
22
Zhen Zhang, Robert C. Bast, Yinhua Yu et al. · Cancer Research · 2004 · 949 citations · Full text
Medicine, Gynecology, Oncology +17
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Yan‐Ming Xu · JAMA · 1998 · 645 citations
Medicine, Gynecology, Oncology +15
Serum protein markers for early detection of ovarian cancer
Gil Mor, Irene Visintin, Yinglei Lai et al. · Proceedings of the National Academy of Sciences · 2005 · 523 citations · Full text
Medicine, Gynecology, Oncology +16